Howard Y. Chang
Howard Y. Chang | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 張元豪 | |||||||||||
| Born | Chang Yuan-hao 1972 (age 53–54) | ||||||||||
| Education | Harvard University (BA, MD) Massachusetts Institute of Technology (PhD) | ||||||||||
| Known for | long non-coding RNA | ||||||||||
| Father | Chang Chau-hsiung | ||||||||||
| Scientific career | |||||||||||
| Fields | Molecular biology | ||||||||||
| Institutions | Amgen, Stanford University | ||||||||||
| Thesis | Molecular studies of Fas signaling and programmed cell death (1998) | ||||||||||
| Doctoral advisor | David Baltimore | ||||||||||
| Other academic advisors | |||||||||||
| Chinese name | |||||||||||
| Traditional Chinese | 張元豪 | ||||||||||
| Simplified Chinese | 张元豪 | ||||||||||
| |||||||||||
Howard Yuan-hao Chang (Chinese: 張元豪; pinyin: Zhāng Yuánháo; born 1972) is a Taiwanese-American physician-scientist who has been the senior vice president of research and chief scientific officer of Amgen since 2024. Previously, he was the Virginia and D. K. Ludwig Professor of Cancer Genomics and of Genetics at the Stanford University School of Medicine, where he was also an HHMI investigator. He is best known for his research on long non-coding RNAs.